$363 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 69.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | Buy | ANTHEM INC | $19,090,000 | +254.6% | 50,000 | +233.3% | 5.26% | +241.7% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $16,315,000 | -17.2% | 260,000 | -24.6% | 4.49% | -20.2% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $15,345,000 | +5.3% | 225,000 | +7.1% | 4.22% | +1.4% |
| CYTK | CYTOKINETICS INC | $13,853,000 | -14.9% | 700,000 | 0.0% | 3.81% | -18.0% | |
| SAGE | Buy | SAGE THERAPEUTICS INC | $12,725,000 | +18.1% | 224,000 | +55.6% | 3.50% | +13.7% |
| BIIB | New | BIOGEN INC | $12,119,000 | – | 35,000 | +100.0% | 3.34% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $10,333,000 | – | 18,500 | +100.0% | 2.84% | – |
| GMED | Buy | GLOBUS MED INCcl a | $10,079,000 | +117.9% | 130,000 | +73.3% | 2.78% | +110.1% |
| MDT | Buy | MEDTRONIC PLC | $9,930,000 | +68.1% | 80,000 | +60.0% | 2.73% | +62.0% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $9,518,000 | – | 65,000 | +100.0% | 2.62% | – |
| SNY | New | SANOFIsponsored adr | $9,216,000 | – | 175,000 | +100.0% | 2.54% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $8,796,000 | -23.0% | 100,000 | -14.9% | 2.42% | -25.8% |
| LHCG | Sell | LHC GROUP INC | $8,411,000 | -20.0% | 42,000 | -23.6% | 2.32% | -22.9% |
| MRTX | MIRATI THERAPEUTICS INC | $8,077,000 | -5.7% | 50,000 | 0.0% | 2.22% | -9.1% | |
| TFX | Buy | TELEFLEX INCORPORATED | $8,036,000 | +61.2% | 20,000 | +66.7% | 2.21% | +55.2% |
| ABC | New | AMERISOURCEBERGEN CORP | $8,014,000 | – | 70,000 | +100.0% | 2.21% | – |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $7,778,000 | -44.7% | 180,000 | -47.8% | 2.14% | -46.8% |
| FATE | Buy | FATE THERAPEUTICS INC | $6,943,000 | +110.5% | 80,000 | +100.0% | 1.91% | +102.9% |
| EW | New | EDWARDS LIFESCIENCES CORP | $6,732,000 | – | 65,000 | +100.0% | 1.85% | – |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $6,650,000 | +283.1% | 125,000 | +212.5% | 1.83% | +269.2% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $6,564,000 | +4.9% | 410,000 | +17.1% | 1.81% | +1.1% |
| DNLI | Sell | DENALI THERAPEUTICS INC | $6,354,000 | +14.7% | 81,000 | -16.5% | 1.75% | +10.5% |
| NVRO | Sell | NEVRO CORP | $6,300,000 | +12.9% | 38,000 | -5.0% | 1.73% | +8.8% |
| NTRA | Buy | NATERA INC | $6,244,000 | +75.7% | 55,000 | +57.1% | 1.72% | +69.4% |
| PKI | Sell | PERKINELMER INC | $6,176,000 | -3.7% | 40,000 | -20.0% | 1.70% | -7.3% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $5,944,000 | +35.5% | 42,000 | -4.5% | 1.64% | +30.6% |
| A | New | AGILENT TECHNOLOGIES INC | $5,912,000 | – | 40,000 | +100.0% | 1.63% | – |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $5,629,000 | -36.1% | 35,000 | -36.4% | 1.55% | -38.4% |
| ACCD | Buy | ACCOLADE INC | $5,431,000 | +59.6% | 100,000 | +33.3% | 1.50% | +53.8% |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $4,857,000 | -64.4% | 30,000 | -82.4% | 1.34% | -65.7% |
| PTCT | Buy | PTC THERAPEUTICS INC | $4,654,000 | -1.8% | 110,100 | +10.0% | 1.28% | -5.4% |
| FOLD | New | AMICUS THERAPEUTICS INC | $4,579,000 | – | 475,000 | +100.0% | 1.26% | – |
| ZLAB | Sell | ZAI LAB LTDadr | $4,425,000 | -26.3% | 25,000 | -44.4% | 1.22% | -29.0% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $4,391,000 | +111.7% | 120,000 | +100.0% | 1.21% | +103.9% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $4,238,000 | -25.0% | 25,000 | -37.5% | 1.17% | -27.7% |
| AGL | New | AGILON HEALTH INC | $4,057,000 | – | 100,000 | +100.0% | 1.12% | – |
| DHR | Sell | DANAHER CORPORATION | $4,025,000 | -55.3% | 15,000 | -62.5% | 1.11% | -56.9% |
| BNTX | New | BIONTECH SEsponsored ads | $3,806,000 | – | 17,000 | +100.0% | 1.05% | – |
| ALKS | New | ALKERMES PLC | $3,678,000 | – | 150,000 | +100.0% | 1.01% | – |
| PNTG | Buy | PENNANT GROUP INC | $3,681,000 | +0.5% | 90,000 | +12.5% | 1.01% | -3.2% |
| REPL | Buy | REPLIMUNE GROUP INC | $3,458,000 | +59.6% | 90,000 | +26.8% | 0.95% | +53.8% |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $3,318,000 | – | 50,000 | +100.0% | 0.91% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $3,073,000 | – | 175,000 | +100.0% | 0.85% | – |
| SIBN | New | SI-BONE INC | $2,832,000 | – | 90,000 | +100.0% | 0.78% | – |
| AXNX | AXONICS INC | $2,536,000 | +5.8% | 40,000 | 0.0% | 0.70% | +1.9% | |
| CCXI | Buy | CHEMOCENTRYX INC | $2,343,000 | -70.5% | 175,000 | +12.9% | 0.64% | -71.6% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $2,212,000 | – | 35,000 | +100.0% | 0.61% | – |
| CERC | Buy | CERECOR INC | $2,207,000 | +21.8% | 675,000 | +12.5% | 0.61% | +17.4% |
| DTIL | New | PRECISION BIOSCIENCES INC | $2,191,000 | – | 175,000 | +100.0% | 0.60% | – |
| AKRO | AKERO THERAPEUTICS INC | $2,109,000 | -14.5% | 85,000 | 0.0% | 0.58% | -17.6% | |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $2,086,000 | -46.9% | 25,000 | -51.9% | 0.57% | -48.8% |
| UNH | New | UNITEDHEALTH GROUP INC | $2,002,000 | – | 5,000 | +100.0% | 0.55% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $1,976,000 | -51.4% | 125,000 | -68.8% | 0.54% | -53.2% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $1,935,000 | +44.6% | 85,000 | +30.8% | 0.53% | +39.5% |
| MCRB | New | SERES THERAPEUTICS INC | $1,789,000 | – | 75,000 | +100.0% | 0.49% | – |
| ONEM | New | 1LIFE HEALTHCARE INC | $1,653,000 | – | 50,000 | +100.0% | 0.46% | – |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $1,653,000 | -25.6% | 30,000 | -30.2% | 0.46% | -28.3% |
| ALT | New | ALTIMMUNE INC | $1,576,000 | – | 160,000 | +100.0% | 0.43% | – |
| HRTX | New | HERON THERAPEUTICS INC | $1,552,000 | – | 100,000 | +100.0% | 0.43% | – |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $1,548,000 | +194.3% | 150,000 | +200.0% | 0.43% | +184.0% |
| AXGN | New | AXOGEN INC | $1,513,000 | – | 70,000 | +100.0% | 0.42% | – |
| KURA | Buy | KURA ONCOLOGY INC | $1,460,000 | -13.9% | 70,000 | +16.7% | 0.40% | -17.1% |
| New | TRILLIUM THERAPEUTICS INC | $1,455,000 | – | 150,000 | +100.0% | 0.40% | – | |
| FMTX | New | FORMA THERAPEUTICS HLDGS INC | $1,120,000 | – | 45,000 | +100.0% | 0.31% | – |
| MSON | MISONIX INC | $998,000 | +13.2% | 45,000 | 0.0% | 0.28% | +9.1% | |
| KDMN | Sell | KADMON HLDGS INC | $871,000 | -25.4% | 225,000 | -25.0% | 0.24% | -27.9% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $734,000 | -4.7% | 75,000 | +15.4% | 0.20% | -8.2% |
| ALEC | Sell | ALECTOR INC | $729,000 | -34.2% | 35,000 | -36.4% | 0.20% | -36.6% |
| CMRX | New | CHIMERIX INC | $600,000 | – | 75,000 | +100.0% | 0.16% | – |
| ARDX | Sell | ARDELYX INC | $531,000 | -15.6% | 70,000 | -26.3% | 0.15% | -18.9% |
| LBPH | LONGBOARD PHARMACEUTICALS IN | $274,000 | -44.2% | 30,000 | 0.0% | 0.08% | -46.4% | |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -20,000 | -100.0% | -0.03% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.11% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -10,000 | -100.0% | -0.32% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -10,000 | -100.0% | -0.37% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -20,000 | -100.0% | -0.43% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.60% | – |
| INSM | Exit | INSMED INC | $0 | – | -70,000 | -100.0% | -0.68% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -50,000 | -100.0% | -0.74% | – |
| PODD | Exit | INSULET CORP | $0 | – | -10,000 | -100.0% | -0.74% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -14,000 | -100.0% | -0.86% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -500,000 | -100.0% | -0.89% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -50,000 | -100.0% | -0.90% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -40,000 | -100.0% | -1.05% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -65,000 | -100.0% | -1.22% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -200,000 | -100.0% | -1.29% | – |
| SGFY | Exit | SIGNIFY HEALTH INC | $0 | – | -160,000 | -100.0% | -1.34% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -20,000 | -100.0% | -1.39% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -175,000 | -100.0% | -1.59% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -25,000 | -100.0% | -1.82% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -90,000 | -100.0% | -1.98% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -150,000 | -100.0% | -2.74% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -50,000 | -100.0% | -2.79% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -35,000 | -100.0% | -2.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-30
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.